Display options
Share it on

Mediators Inflamm. 1995;4(2):90-4. doi: 10.1155/S0962935195000147.

The effect of lysolecithin on prostanoid and platelet-activating factor formation by human gall-bladder mucosal cells.

Mediators of inflammation

M K Nag, Y G Deshpande, D Beck, A Li, D L Kaminski

Affiliations

  1. Department of Surgery St Louis University Health Sciences Center 3635 Vista Ave. at Grand Blvd P.O. Box 15250 St Louis MO 63110-0250 USA.

PMID: 18475621 PMCID: PMC2365627 DOI: 10.1155/S0962935195000147

Abstract

It has been demonstrated that lysolecithin (lysophosphatidyl choline, LPC) produces experimental cholecystitis in cats mediated by arachidonic acid metabolites. LPC is a cytolytic agent that has been postulated as a contributing factor in the development of cholecystitis in humans. The purpose of this research was to evaluate the effect of LPC on human gall-bladder mucosal cell phospholipase A(2) and cyclooxygenase activity. Gall-bladder mucosal cells were isolated from the gall-bladders of patients undergoing routine cholecystectomy. Fresh, isolated cells were maintained in tissue culture and stimulated with varying doses of LPC. Platelet-activating factor concentration was quantitated as an index of phospholipase A(2) activity and prostanoids were measured as an index of cyclooxygenase activity. Also, the effect of LPC on cyclooxygenase 1 and 2 expression in microsomal protein was evaluated. LPC caused dose related increases in 6-keto-PGF(1alpha) and PAF produced by human gall-bladder mucosal cells. Exposure of human gall-bladder mucosal cells to LPC failed to elicit expression of constitutive cyclooxygenase-1, while the expression of inducible cyclooxygenase-2 was increased. The results of this study indicate that LPC induces the formation of prostanoids and PAF by human gall-bladder mucosal cells, suggesting that this substance may promote the development of gall-bladder inflammation.

References

  1. Scand J Clin Lab Invest. 1968;21(2):168-76 - PubMed
  2. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
  3. J Biol Chem. 1990 Jul 5;265(19):10805-8 - PubMed
  4. Prostaglandins. 1994 Apr;47(4):319-30 - PubMed
  5. Acta Chir Scand. 1969;135(3):213-7 - PubMed
  6. Gastroenterology. 1988 Aug;95(2):508-23 - PubMed
  7. Gastroenterol Jpn. 1991 Oct;26(5):633-44 - PubMed
  8. Biochem Biophys Res Commun. 1992 Jul 15;186(1):475-82 - PubMed
  9. Chem Biol Interact. 1991;78(1):67-75 - PubMed
  10. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2046-50 - PubMed
  11. Hepatology. 1990 Jun;11(6):1003-9 - PubMed
  12. Mol Endocrinol. 1989 Nov;3(11):1714-23 - PubMed
  13. FASEB J. 1993 Feb 1;7(2):339-48 - PubMed
  14. J Lab Clin Med. 1983 May;101(5):699-707 - PubMed
  15. Am J Physiol. 1986 Nov;251(5 Pt 1):G701-9 - PubMed
  16. Dig Dis Sci. 1989 Nov;34(11):1770-6 - PubMed
  17. Anal Biochem. 1976 May 7;72:248-54 - PubMed
  18. Biochim Biophys Acta. 1979 Aug 20;559(2-3):259-87 - PubMed
  19. Biochem Biophys Res Commun. 1992 Sep 16;187(2):1123-7 - PubMed
  20. Eur J Pharmacol. 1992 Feb 11;211(2):177-82 - PubMed
  21. Ann Surg. 1990 Oct;212(4):455-61 - PubMed
  22. Am J Physiol. 1990 Nov;259(5 Pt 1):C697-708 - PubMed
  23. Prostaglandins. 1994 Mar;47(3):233-45 - PubMed
  24. Anal Biochem. 1978 Jul 1;87(2):386-96 - PubMed

Publication Types